University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 1 of 18
Study EHR Risk Stratification Tools
NCT06995378
Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor
NCT07599592
Health And Response: Digital Markers for Outcomes in Perinatal Depression Treatment Study
NCT07577947
fNIRS for Disorders of Consciousness
NCT07485361
Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles County
NCT07467018
A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression
NCT06906939
The STOP-HPV Scale Up Study
NCT06831383
Effect of a Daily Supplement on Plasma PAI-1 Levels
NCT07469475
Sleep Learning Education and Empowerment for Older Korean Immigrants
NCT07387406
Immune Tolerance Induction After Liver Transplantation
NCT07269041
Coaching and Leadership in Autism Support Settings
NCT07276750
Safety Profile of Psilocybin for Cocaine Use Disorder
NCT06102434
AI-Driven Consent Simplification Study
NCT07303517
RCT of Psilocybin-assisted CBT for Depression
NCT07281352
Arrival Time Implementation
NCT07314697
Phase 1 Pilot of a Pragmatic Trial of EAET for Veterans With Chronic Pain
NCT07218757
Optimizing Proton Pump Inhibitors (PPI) Prescribing With EHR-Based Decision Support
NCT06998966
Intercostal Cryoanalgesia in Double Lung Transplant Recipients
NCT07281118
Clinical Outcomes and Major Adverse Events in Patients Treated With Physician-Modified Fenestrated and Branched Stent Grafts
NCT06526676
Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum
NCT07283042
Inter-Brain Synchrony in Schizophrenia
NCT07177261
Laryngeal and Vocal Tract Strategies to Reduce Vocal Fold Contact Pressure
NCT06165536
California MEPS Hub
NCT07433985
Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants
NCT07236892
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
NCT06859710
Help Texts Grief Intervention for Bereaved College Students
NCT07228260
Effects of Pomegranate Juice on Ulcerative Colitis
NCT07115862
New T-UP: Engaging Vulnerable Students in Diabetes Prevention
NCT07225218
A Mindfulness-Based Intervention to Reduce Stress Through the Cultivation of Loving-Kindness, Compassion, Joy, and Equanimity in Healthcare Professionals
NCT07283744
Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
NCT07449039
Telerehabilitation In The Home After Stroke
NCT06682429
Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)
NCT07179601
PH Sensitive MRI Based Resections of Glioblastoma
NCT06176066
Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer
NCT07208084
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
NCT06440707
RCT for Latina Mental Health Using Web-Based Apps
NCT06874790
Training Reward Responsiveness Through Virtual Reality
NCT07219875
High Potency Cannabis: Acute and Protracted Effects
NCT06859723
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
NCT06915792
Effect of Snacks on Aging
NCT06879626
Evaluating a Our Practice Advisory (OPA) to Optimize Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) Test Orders
NCT06993805
A Study to Prevent Infantile Spasms Relapse
NCT06819670
Age-dependent Effects of Smoked and Oral Delta-9-THC
NCT05865470
Ultrasound Stimulation for Patients in a Disorder of Consciousness
NCT06939348
Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
NCT06847165
In-patient SCC TMS
NCT05645575
Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
NCT06920940
Remimazolam for Cataract Surgery
NCT05980117
Evaluating AI-Generated Plain Language Summaries on Patient Comprehension of Ophthalmology Notes Among English-Speaking Patients
NCT06859216
Treatment of Borderline Personality Disorder With rTMS
NCT07197502
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of California, Los Angeles pipeline card: 897 registered trials from official public datasets.Report a data error.